These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 27750219)

  • 1. Improving anticancer drug development begins with cell culture: misinformation perpetrated by the misuse of cytotoxicity assays.
    Eastman A
    Oncotarget; 2017 Jan; 8(5):8854-8866. PubMed ID: 27750219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro combination treatment with perifosine and UCN-01 demonstrates synergism against prostate (PC-3) and lung (A549) epithelial adenocarcinoma cell lines.
    Dasmahapatra GP; Didolkar P; Alley MC; Ghosh S; Sausville EA; Roy KK
    Clin Cancer Res; 2004 Aug; 10(15):5242-52. PubMed ID: 15297428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiologically relevant in vitro tumor models for drug screening.
    Das V; Bruzzese F; Konečný P; Iannelli F; Budillon A; Hajdúch M
    Drug Discov Today; 2015 Jul; 20(7):848-55. PubMed ID: 25908576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mangiferin enhances the sensitivity of human multiple myeloma cells to anticancer drugs through suppression of the nuclear factor κB pathway.
    Takeda T; Tsubaki M; Kino T; Kawamura A; Isoyama S; Itoh T; Imano M; Tanabe G; Muraoka O; Matsuda H; Satou T; Nishida S
    Int J Oncol; 2016 Jun; 48(6):2704-12. PubMed ID: 27035859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Target Gene Discovery for Novel Therapeutic Agents in Cancer Treatment.
    Tiwari S; Ammerpohl O; Kalthoff H
    Methods Mol Biol; 2016; 1381():181-200. PubMed ID: 26667461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel doxorubicin-mitomycin C co-encapsulated nanoparticle formulation exhibits anti-cancer synergy in multidrug resistant human breast cancer cells.
    Shuhendler AJ; Cheung RY; Manias J; Connor A; Rauth AM; Wu XY
    Breast Cancer Res Treat; 2010 Jan; 119(2):255-69. PubMed ID: 19221875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of novel drugs for promising targets.
    Martell RE; Brooks DG; Wang Y; Wilcoxen K
    Clin Ther; 2013 Sep; 35(9):1271-81. PubMed ID: 24054704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of ceritinib (LDK378) on enhancement of chemotherapeutic agents in ABCB1 and ABCG2 overexpressing cells in vitro and in vivo.
    Hu J; Zhang X; Wang F; Wang X; Yang K; Xu M; To KK; Li Q; Fu L
    Oncotarget; 2015 Dec; 6(42):44643-59. PubMed ID: 26556876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Vivo Pharmacology Models for Cancer Target Research.
    Chen D; An X; Ouyang X; Cai J; Zhou D; Li QX
    Methods Mol Biol; 2019; 1953():183-211. PubMed ID: 30912023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro assays and techniques utilized in anticancer drug discovery.
    Ediriweera MK; Tennekoon KH; Samarakoon SR
    J Appl Toxicol; 2019 Jan; 39(1):38-71. PubMed ID: 30073673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Green tea: an effective synergist with anticancer drugs for tertiary cancer prevention.
    Fujiki H; Suganuma M
    Cancer Lett; 2012 Nov; 324(2):119-25. PubMed ID: 22626556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disrupting cancer cells' biocircuits with interactome-based drugs: is 'clinical' innovation realistic?
    Roukos DH
    Expert Rev Proteomics; 2012 Aug; 9(4):349-53. PubMed ID: 22967071
    [No Abstract]   [Full Text] [Related]  

  • 13. Farnesyltransferase inhibitor R115777 inhibits cell growth and induces apoptosis in mantle cell lymphoma.
    Rolland D; Camara-Clayette V; Barbarat A; Salles G; Coiffier B; Ribrag V; Thieblemont C
    Cancer Chemother Pharmacol; 2008 Apr; 61(5):855-63. PubMed ID: 17639395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of Multicellular Tumor Spheroids with Microwell-Based Agarose Scaffolds for Drug Testing.
    Gong X; Lin C; Cheng J; Su J; Zhao H; Liu T; Wen X; Zhao P
    PLoS One; 2015; 10(6):e0130348. PubMed ID: 26090664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin sensitizes sorafenib to inhibit postoperative recurrence and metastasis of hepatocellular carcinoma in orthotopic mouse models.
    You A; Cao M; Guo Z; Zuo B; Gao J; Zhou H; Li H; Cui Y; Fang F; Zhang W; Song T; Li Q; Zhu X; Yin H; Sun H; Zhang T
    J Hematol Oncol; 2016 Mar; 9():20. PubMed ID: 26957312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The anti-fibrotic agent pirfenidone synergizes with cisplatin in killing tumor cells and cancer-associated fibroblasts.
    Mediavilla-Varela M; Boateng K; Noyes D; Antonia SJ
    BMC Cancer; 2016 Mar; 16():176. PubMed ID: 26935219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JFCR39, a panel of 39 human cancer cell lines, and its application in the discovery and development of anticancer drugs.
    Kong D; Yamori T
    Bioorg Med Chem; 2012 Mar; 20(6):1947-51. PubMed ID: 22336246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
    Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of anticancer effects of newly synthesized dihydropyridine derivatives in comparison to verapamil and doxorubicin on T47D parental and resistant cell lines in vitro.
    Bazargan L; Fouladdel S; Shafiee A; Amini M; Ghaffari SM; Azizi E
    Cell Biol Toxicol; 2008 Apr; 24(2):165-74. PubMed ID: 17805981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA-PKcs, a novel functional target of acriflavine, mediates acriflavine's p53-dependent synergistic anti-tumor efficiency with melphalan.
    Cao J; Lin G; Gong Y; Pan P; Ma Y; Huang P; Ying M; Hou T; He Q; Yang B
    Cancer Lett; 2016 Dec; 383(1):115-124. PubMed ID: 27693638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.